PT65946B - Process for the manufacture of glucosamine derivatives - Google Patents

Process for the manufacture of glucosamine derivatives

Info

Publication number
PT65946B
PT65946B PT65946A PT6594676A PT65946B PT 65946 B PT65946 B PT 65946B PT 65946 A PT65946 A PT 65946A PT 6594676 A PT6594676 A PT 6594676A PT 65946 B PT65946 B PT 65946B
Authority
PT
Portugal
Prior art keywords
manufacture
glucosamine derivatives
glucosamine
derivatives
Prior art date
Application number
PT65946A
Other languages
English (en)
Portuguese (pt)
Other versions
PT65946A (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT65946A publication Critical patent/PT65946A/pt
Publication of PT65946B publication Critical patent/PT65946B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT65946A 1975-12-10 1976-12-09 Process for the manufacture of glucosamine derivatives PT65946B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (2)

Publication Number Publication Date
PT65946A PT65946A (en) 1977-01-01
PT65946B true PT65946B (en) 1978-06-14

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65946A PT65946B (en) 1975-12-10 1976-12-09 Process for the manufacture of glucosamine derivatives

Country Status (30)

Country Link
JP (1) JPS5273820A (xx)
AR (2) AR224091A1 (xx)
AT (1) AT365607B (xx)
AU (1) AU508764B2 (xx)
BE (1) BE849214A (xx)
CA (1) CA1262400A (xx)
CH (2) CH613709A5 (xx)
CS (4) CS205025B2 (xx)
DD (1) DD129781A5 (xx)
DE (1) DE2655500A1 (xx)
DK (1) DK154654C (xx)
ES (2) ES454118A1 (xx)
FI (1) FI64164C (xx)
FR (1) FR2361902A1 (xx)
GB (1) GB1570625A (xx)
GR (1) GR61647B (xx)
HK (1) HK32883A (xx)
HU (1) HU177970B (xx)
IE (1) IE44190B1 (xx)
IL (1) IL51076A (xx)
MY (1) MY8400123A (xx)
NL (1) NL7613666A (xx)
NO (1) NO144850C (xx)
NZ (1) NZ182837A (xx)
PL (4) PL110787B1 (xx)
PT (1) PT65946B (xx)
SE (1) SE445923B (xx)
SG (1) SG11083G (xx)
SU (3) SU660589A3 (xx)
ZA (1) ZA767333B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (de) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (xx) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
JP4875612B2 (ja) * 2005-04-27 2012-02-15 真司 武岡 カチオン性アミノ酸型脂質
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
EP3387005B1 (en) * 2015-12-10 2022-08-24 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
EP3672939A1 (en) 2017-08-21 2020-07-01 Celgene Corporation Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
IE44190B1 (en) 1981-09-09
FI64164C (fi) 1983-10-10
DE2655500A1 (de) 1977-06-23
FR2361902B1 (xx) 1980-11-07
CS205025B2 (en) 1981-04-30
PL112672B1 (en) 1980-10-31
IL51076A (en) 1980-09-16
SG11083G (en) 1983-09-16
NO144850C (no) 1981-11-25
PL110794B1 (en) 1980-07-31
FI64164B (fi) 1983-06-30
ATA909276A (de) 1981-06-15
HK32883A (en) 1983-09-02
DD129781A5 (de) 1978-02-08
DK154654B (da) 1988-12-05
AR220686A1 (es) 1980-11-28
CS205028B2 (en) 1981-04-30
CH613709A5 (en) 1979-10-15
SU1060118A3 (ru) 1983-12-07
CS205027B2 (en) 1981-04-30
AU508764B2 (en) 1980-04-03
AT365607B (de) 1982-02-10
CH614718A5 (en) 1979-12-14
IE44190L (en) 1977-06-10
DK154654C (da) 1989-05-08
MY8400123A (en) 1984-12-31
CA1262400A (en) 1989-10-17
HU177970B (en) 1982-02-28
CS205026B2 (en) 1981-04-30
BE849214A (fr) 1977-06-09
ES465514A1 (es) 1978-09-16
DK552476A (da) 1977-06-11
JPS638118B2 (xx) 1988-02-19
NO764191L (xx) 1977-06-13
SU660589A3 (ru) 1979-04-30
PT65946A (en) 1977-01-01
SE7613851L (sv) 1977-06-11
DE2655500C2 (xx) 1988-12-22
JPS5273820A (en) 1977-06-21
NO144850B (no) 1981-08-17
NL7613666A (nl) 1977-06-14
AU2042276A (en) 1978-06-15
AR224091A1 (es) 1981-10-30
NZ182837A (en) 1978-07-28
SE445923B (sv) 1986-07-28
FI763541A (xx) 1977-06-11
ES454118A1 (es) 1978-03-01
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
ZA767333B (en) 1977-11-30
PL110787B1 (en) 1980-07-31
SU747430A3 (ru) 1980-07-23
IL51076A0 (en) 1977-02-28
PL194291A1 (pl) 1978-10-23
PL110353B1 (en) 1980-07-31
FR2361902A1 (fr) 1978-03-17

Similar Documents

Publication Publication Date Title
PT65946A (en) Process for the manufacture of glucosamine derivatives
YU39479B (en) Process for the manufacture of thieno-pyridine derivatives
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
GB1542442A (en) Process for the manufacture of nucleosides
HU171396B (hu) Sposob poluchenija proizvodnykh rifamicina
GB1517423A (en) Process for the preparation of diaryl-carbonates
PT65486B (en) Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
HU171395B (hu) Sposob poluchenija proizvodnykh rifamicina
PT65255B (en) Process for the preparation of 11-desoxy-16-aryloxy-w-tetranorprostaglandins
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
YU187776A (en) Process for prepring derivatives of diaminoandrostane
GB1520681A (en) Process for the production of phoroglucinol
ZA76474B (en) Process for the preparation of thienopyridine derivatives
GB1551120A (en) Process for the manufacture of 16-20-keto-steroids
PT65120A (en) Process for the preparation of novel diureide derivatives
GB1548670A (en) Pricess for the production of 2-amino-3-hydroxypyridines
ZA763221B (en) Process for the preparation of 3-bromobenzalidehyde
GB1477990A (en) Process for the preparation of thieno-pyridine derivatives
GB1543390A (en) Process for the production of 2-amino-3-hydroxypyridine derivatives
CH613691A5 (en) Process for the preparation of novel 1-indolinylguanidine derivatives
HU172451B (hu) Sposob poluchenija proizvodnykh beta-nitropirazola
GB1546087A (en) Process for the manufacture of hydrazobenzene derivatives
PT65357B (en) Process for the preparation of gamma-pyrones
PT65176B (en) Process for the preparation of 6-aminomethylated 3-oxygenated cholest-5-enes